Abbott LaboratoriesvsUL Solutions

ABT and ULS stock compared: price, dividend, valuation and results, from SEC filings.

ABT

Abbott Laboratories

$108.52

Value $189B

+1.18%
ABT's page

ULS

UL Solutions Inc.

$80.36

Value $16.2B

-1.46%
ULS's page

Abbott Laboratories (ABT) has a market value of $189B and UL Solutions (ULS) $16.2B. Over the last year, with dividends, ABT moved -13.7% and ULS -6.5%. The P/E is 40.1 for ABT and 31.5 for ULS. Dividend yield: ABT 2.32%, ULS 0.70%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ABT$189B

    ULS$16.2B

    ABT is 12 times ULS

  • Revenue, 12 months

    ABT$48.2B

    ULS$3.2B

    ABT is 15 times ULS

  • Net income, 12 months

    ABT$4.7B

    ULS$513M

    ABT is 9.2 times ULS

  • Operating margin

    ABT13.8%

    ULS17.8%

    4.0 points apart

  • ROIC

    ABT6.3%

    ULS21.8%

    15.5 points apart

  • P/E

    ABT40.1

    ULS31.5

    ABT is 1.3 times ULS

  • Dividend yield

    ABT2.3%

    ULS0.7%

    1.6 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ABT-13.7%

ULS-6.5%

80100120DecFebAprJunAugOct
Returns by period
PeriodABTWith dividendsULSWith dividends
1 year since November 12, 2025-13.7%Price -15.8%-6.5%Price -7.1%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ABTAbbott LaboratoriesULSUL Solutions

Valuation

ABTULS
Valuation
Price$108.52$80.36
Market value$189B$16.2B
Enterprise value (EV)$215B$15.9B
P/E40.131.5
P/E, 5-year median33.7–
P/B3.79.5
EV/EBIT32.428.0
Free cash flow yield3.6%3.0%

Results and growth

ABTULS
Results and growth
Revenue, 12 months$48.2B$3.2B
Net income, 12 months$4.7B$513M
Free cash flow, 12 months$6.8B$481M
Earnings per share, 12 months$2.69$2.52
Revenue growth, year on year5.7%6.4%
Revenue growth a year, past+5.1%over 5 years+6.6%over 3 years
EPS growth a year, past+8.3%over 5 years+2.9%over 3 years

Margins and returns on capital

ABTULS
Margins and returns on capital
Gross margin56.9%50.7%
Operating margin13.8%17.8%
Net margin9.8%16.1%
ROIC6.3%21.8%
ROE9.1%36.3%

Balance sheet

ABTULS
Balance sheet
Cash$4.3B$1.0B
Total debt$31.2B$934M
Net debt / EBITDA3.3-0.3
Interest cover6.7×20.3×

Dividends and buybacks

ABTULS
Dividends and buybacks
Dividend yield2.3%0.7%
Dividend per share, 12 months$2.52$0.57
Dividend growth a year, past+10.4%over 5 years–
Buyback yield0.5%–
Shareholder yield2.8%0.7%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ABT or ULS

Didn't find what you were looking for?

Ask us
Which is bigger, Abbott Laboratories or UL Solutions?

By market value, Abbott Laboratories ($189B) is about 11.7 times UL Solutions ($16.2B), at today's prices.

How did ABT and ULS stock do over the last 1 years?

Since November 12, 2025, ABT's price moved -15.8% and ULS's -7.1%. With dividends: ABT -13.7% (-13.7% a year), ULS -6.5% (-6.5% a year). Past returns do not predict future ones.

Which pays the higher dividend, ABT or ULS?

The dividend yield at today's price is 2.32% for Abbott Laboratories and 0.70% for UL Solutions. Over the last twelve months they paid $2.52 and $0.57 per share.

What is the P/E of ABT and ULS?

At today's price, the P/E is 40.1 for ABT and 31.5 for ULS. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Abbott Laboratories or UL Solutions?

Over the last twelve months, the net margin was 9.8% for Abbott Laboratories and 16.1% for UL Solutions, and the operating margin 13.8% and 17.8%. Revenue was $48.2B and $3.2B.

Which is the better investment, Abbott Laboratories or UL Solutions?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.